Discontinuation report CLINDAMYCIN INJECTION USP
| Report ID | 12122 |
| Drug Identification Number | 02230535 |
| Brand name | CLINDAMYCIN INJECTION USP |
| Common or Proper name | CLINDAMYCIN |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | CLINDAMYCIN |
| Strength(s) | 150MG |
| Dosage form(s) | LIQUID |
| Route of administration | INTRAVENOUS |
| Packaging size | 120ML VIAL |
| ATC code | J01FF |
| ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2017-08-01 |
| Actual discontinuation date | 2017-08-01 |
| Remaining supply date | 2017-07-24 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | 60ML VIAL FORMAT AVAILABLE |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2017-10-18 | French | Compare |
| v3 | 2017-10-18 | English | Compare |
| v2 | 2017-06-06 | French | Compare |
| v1 | 2017-06-06 | English | Compare |
Showing 1 to 4 of 4